Company Overview
- Headquarters
- 343 Oyster Point Blvd Suite 120, South San Francisco CA
- Website
- neuron23.com
- Phone
- (310) 403-8951
- Employees
- 55
- Founded in
- 2018
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$50B
Who is Neuron23
Neuron23 Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California. Founded in 2018, the company employs 55 people and generates $50 million in annual revenue. Neuron23 specializes in developing precision medicines for genetically defined neurological and immunological diseases. Their approach combines cutting-edge human genetics research with a sophisticated drug discovery and biomarker platform that leverages machine learning and artificial intelligence. The company's therapeutic focus areas include neurodegenerative diseases, neuroinflammatory diseases, and systemic autoimmune and inflammatory diseases. Neuron23 aims to advance treatments for these devastating conditions through its innovative platform and expertise. For more information about Neuron23 and its groundbreaking work, visit their website at neuron23.com.
Company Leadership
Neuron23 Industry Tags
Companies Similar to Neuron23
Analyze industry trends and opportunities by examining competitors and companies comparable to Neuron23, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | Cambridge, MA | |||
| 50M | 59 | Foster City, CA | ||
| 50M | 74 | San Diego, CA | ||
| 50M | 181 | New Haven, CT | 2017 | |
| 50M | 58 | Carlsbad, CA |